1
|
Flickering in Information Spreading Precedes Critical Transitions in Financial Markets. Sci Rep 2019; 9:5671. [PMID: 30952925 PMCID: PMC6450864 DOI: 10.1038/s41598-019-42223-9] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2019] [Accepted: 03/21/2019] [Indexed: 11/08/2022] Open
Abstract
As many complex dynamical systems, financial markets exhibit sudden changes or tipping points that can turn into systemic risk. This paper aims at building and validating a new class of early warning signals of critical transitions. We base our analysis on information spreading patterns in dynamic temporal networks, where nodes are connected by short-term causality. Before a tipping point occurs, we observe flickering in information spreading, as measured by clustering coefficients. Nodes rapidly switch between "being in" and "being out" the information diffusion process. Concurrently, stock markets start to desynchronize. To capture these features, we build two early warning indicators based on the number of regime switches, and on the time between two switches. We divide our data into two sub-samples. Over the first one, using receiver operating curve, we show that we are able to detect a tipping point about one year before it occurs. For instance, our empirical model perfectly predicts the Global Financial Crisis. Over the second sub-sample, used as a robustness check, our two statistical metrics also capture, to a large extent, the 2016 financial turmoil. Our results suggest that our indicators have informational content about a future tipping point, and have therefore strong policy implications.
Collapse
|
2
|
Geva A, Gronsbell JL, Cai T, Cai T, Murphy SN, Lyons JC, Heinz MM, Natter MD, Patibandla N, Bickel J, Mullen MP, Mandl KD. A Computable Phenotype Improves Cohort Ascertainment in a Pediatric Pulmonary Hypertension Registry. J Pediatr 2017; 188. [PMID: 28625502 PMCID: PMC5572538 DOI: 10.1016/j.jpeds.2017.05.037] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
OBJECTIVES To compare registry and electronic health record (EHR) data mining approaches for cohort ascertainment in patients with pediatric pulmonary hypertension (PH) in an effort to overcome some of the limitations of registry enrollment alone in identifying patients with particular disease phenotypes. STUDY DESIGN This study was a single-center retrospective analysis of EHR and registry data at Boston Children's Hospital. The local Informatics for Integrating Biology and the Bedside (i2b2) data warehouse was queried for billing codes, prescriptions, and narrative data related to pediatric PH. Computable phenotype algorithms were developed by fitting penalized logistic regression models to a physician-annotated training set. Algorithms were applied to a candidate patient cohort, and performance was evaluated using a separate set of 136 records and 179 registry patients. We compared clinical and demographic characteristics of patients identified by computable phenotype and the registry. RESULTS The computable phenotype had an area under the receiver operating characteristics curve of 90% (95% CI, 85%-95%), a positive predictive value of 85% (95% CI, 77%-93%), and identified 413 patients (an additional 231%) with pediatric PH who were not enrolled in the registry. Patients identified by the computable phenotype were clinically distinct from registry patients, with a greater prevalence of diagnoses related to perinatal distress and left heart disease. CONCLUSIONS Mining of EHRs using computable phenotypes identified a large cohort of patients not recruited using a classic registry. Fusion of EHR and registry data can improve cohort ascertainment for the study of rare diseases. TRIAL REGISTRATION ClinicalTrials.gov: NCT02249923.
Collapse
Affiliation(s)
- Alon Geva
- Computational Health Informatics Program, Boston Children’s Hospital, Boston, MA,Division of Critical Care Medicine, Department of Anesthesiology, Perioperative, and Pain Medicine, Boston Children’s Hospital, Boston, MA,Department of Anaesthesia, Harvard Medical School, Boston, MA
| | - Jessica L. Gronsbell
- Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA
| | - Tianxi Cai
- Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA
| | - Tianrun Cai
- Division of Rheumatology, Immunology and Allergy, Brigham and Women’s Hospital, Boston, MA
| | - Shawn N. Murphy
- Department of Research Information Services and Computing, Partners Healthcare, Boston, MA,Department of Neurology, Massachusetts General Hospital, Boston, MA,Department of Biomedical Informatics, Harvard Medical School, Boston, MA
| | - Jessica C. Lyons
- Department of Biomedical Informatics, Harvard Medical School, Boston, MA
| | - Michelle M. Heinz
- Computational Health Informatics Program, Boston Children’s Hospital, Boston, MA
| | - Marc D. Natter
- Computational Health Informatics Program, Boston Children’s Hospital, Boston, MA,Department of Pediatrics, Harvard Medical School, Boston, MA
| | - Nandan Patibandla
- Information Services Department, Boston Children’s Hospital, Boston, MA
| | - Jonathan Bickel
- Computational Health Informatics Program, Boston Children’s Hospital, Boston, MA,Information Services Department, Boston Children’s Hospital, Boston, MA,Department of Pediatrics, Harvard Medical School, Boston, MA
| | - Mary P. Mullen
- Department of Cardiology, Boston Children’s Hospital, Boston, MA,Department of Pediatrics, Harvard Medical School, Boston, MA
| | - Kenneth D. Mandl
- Computational Health Informatics Program, Boston Children’s Hospital, Boston, MA,Department of Biomedical Informatics, Harvard Medical School, Boston, MA,Department of Pediatrics, Harvard Medical School, Boston, MA
| | | |
Collapse
|
3
|
Agniel D, Cai T. Analysis of multiple diverse phenotypes via semiparametric canonical correlation analysis. Biometrics 2017; 73:1254-1265. [PMID: 28407213 DOI: 10.1111/biom.12690] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2015] [Revised: 02/01/2017] [Accepted: 02/01/2017] [Indexed: 11/30/2022]
Abstract
Studying multiple outcomes simultaneously allows researchers to begin to identify underlying factors that affect all of a set of diseases (i.e., shared etiology) and what may give rise to differences in disorders between patients (i.e., disease subtypes). In this work, our goal is to build risk scores that are predictive of multiple phenotypes simultaneously and identify subpopulations at high risk of multiple phenotypes. Such analyses could yield insight into etiology or point to treatment and prevention strategies. The standard canonical correlation analysis (CCA) can be used to relate multiple continuous outcomes to multiple predictors. However, in order to capture the full complexity of a disorder, phenotypes may include a diverse range of data types, including binary, continuous, ordinal, and censored variables. When phenotypes are diverse in this way, standard CCA is not possible and no methods currently exist to model them jointly. In the presence of such complications, we propose a semi-parametric CCA method to develop risk scores that are predictive of multiple phenotypes. To guard against potential model mis-specification, we also propose a nonparametric calibration method to identify subgroups that are at high risk of multiple disorders. A resampling procedure is also developed to account for the variability in these estimates. Our method opens the door to synthesizing a wide array of data sources for the purposes of joint prediction.
Collapse
Affiliation(s)
- Denis Agniel
- Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts
| | - Tianxi Cai
- Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts
| |
Collapse
|